Skip to main content

Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma

Completed · Phase 2 · NCT06102005

Conditions: Asthma

At a glance

Research payments reported, 2025
$7.7M
U.S. investigators named
48
Sites paid
45
Planned or actual enrollment
685

About the trial

Sponsor
Sanofi
Tested
Lunsekimig (drug), Placebo (drug)
Dates
Started 2023-10-16; completion 2026-03-11
Results posted
Not yet

This is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma.

From ClinicalTrials.gov, last updated 2026-03-17. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Sanofi US Services Inc. reported $7.7M in research payments for this study in 2025 (491 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Ib Miami LLC $1.1M
  • Qway Research Llc $810,716
  • Clintex Research Group Inc $609,864
  • Ok Clinical Research LLC $505,771
  • High Quality Research Inc $488,926
  • New Access Research and Medical Services Inc $438,718
  • Metroplex Pulmonary and Sleep Center $379,854
  • Elligo Health Research Inc $379,226
  • Deluxe Health Center $340,878
  • Pines Care Research Center Llc $294,801
  • Crn Clinical Research Network LLC $263,635
  • Beautiful Minds Medical Center Llc $218,011
  • Allianz Research Institute Co Llc $184,405
  • Orion Clinical Research $169,910
  • Western States Clinical Research in $142,427
  • Javara Inc $124,898
  • The Regents of the University of Michigan $124,675
  • Brigham and Women's Hospital, MA $103,917
  • Midwest Clinical Research Center St Louis $97,936
  • Allergy Asthma Associates of Santa Clara Valley A Medical Corp $83,492
  • Toledo Institute of Clinical Resear Inc $82,173
  • Howland Allergy and Asthma PLLC $71,684
  • Sarasota Fl Clinical Research Llc Sarasota Clinical Research $66,216
  • Amicis Research Center Llc $64,726
  • Baylor College of Medicine $53,570
  • Western Sky Medical Research $48,825
  • California Allergy and Asthma Medical Group $48,161
  • Vast Clinical Research Llc $46,001
  • Innovo Research Inc $45,850
  • Empirican Prn Inc Circuit Clinical $38,542
  • American Carolina Clinical Research $38,212
  • Velocity Clinical Research Inc $36,130
  • Icahn School of Medicine at Mount Sinai $32,520
  • Epimrd Inc Western Sky Medical Research $30,039
  • Ricardo Antonio Tan MD Inc $27,772
  • Allergy and Clinical Immunology Associates, PC $23,498
  • Allergy and Asthma Associates of Santa Clara Valley Research Center $21,850
  • Appalachian Clinical Research $20,903
  • Allergy and Asthma Associates of Sa Clara Valley Research Center $19,463
  • Clinical Trials Management Services, Llc $18,067
  • Allergy, Asthma and Immunology Associates, Ltd $13,398
  • Studyops Inc $12,630
  • Advanced Research Institute New Port Richey $7,700
  • Yuma Clinical Trials Llc $7,500
  • Clinical Research Associates of Central PA LLC $4,575

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.